Sylvain Routier

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 7.8

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

5 out of 5,069

Centre National De La Recherche Scientifique

Institut National De La Sante Et De La Recherche Medicale

patents

4. 2 out of 290

Les Laboratoires Servier

Centre Hospitalier Régional Universitaire De Tours

patents

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11932638 - Ion channel inhibitor compounds for cancer treatment (2024-03-19),

2. 10906900 - Compounds for using in imaging and particularly for the diagnosis of neurodegenerative diseases (2021-02-02),

3. 10669288 - Lanthanide complexes based on triethylenetetramine-N,N,N',N″,N′″,N′″-hexaacetic acid derivatives (2020-06-02),

4. 10202372 - Trisubstituted pyrido[2,3-D]pyrimidines, methods for preparing same and therapeutic uses thereof (2019-02-12),

5. 10059704 - 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof (2018-08-28),

6. 7638630 - 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors (2009-12-29),

7. 7202255 - Substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same (2007-04-10),

8. 7001906 - Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for the production thereof and pharmaceutical compositions containing said derivatives (2006-02-21),

Title: Unraveling the Inventive Mind of Sylvain Routier

Introduction: Sylvain Routier, a seasoned inventor hailing from Tigy, France, has left an indelible mark on the realm of innovation with his relentless pursuit of groundbreaking ideas. With a notable portfolio boasting 8 patents, Routier continues to push the boundaries of scientific exploration.

Latest Patents:

1. Ion channel inhibitor compounds for cancer treatment: Routier's pioneering work in developing compounds aimed at inhibiting ion channels for cancer treatment underscores his commitment to advancing medical solutions.

2. Compounds for using in imaging and particularly for the diagnosis of neurodegenerative diseases: His innovative compounds designed for imaging and diagnosing neurodegenerative diseases highlight his contribution to the field of medical diagnostics.

Career Highlights: Routier's professional journey has seen him collaborate with esteemed organizations such as Universite D'Orleans and Les Laboratoires Servier, where he has honed his skills and made significant strides in the realm of scientific innovation. His expertise and dedication have paved the way for new advancements in pharmaceuticals and medical diagnostics.

Collaborations: Throughout his career, Routier has had the privilege of working alongside accomplished individuals such as Franck Suzenet and John Hickman. These collaborations have not only enriched his own creative process but have also led to the development of impactful inventions that have the potential to shape the future of healthcare.

Conclusion: Sylvain Routier stands as a beacon of inspiration in the world of inventing, showcasing the transformative power of innovation and perseverance. His unwavering dedication to pushing the boundaries of what is possible serves as a testament to his status as a pioneering inventor, leaving a lasting legacy in the ever-evolving landscape of scientific discovery.

This text is generated by artificial intelligence and may not be accurate.